HomeAkonni Biosystems Inc.

Akonni Biosystems Inc.

TruDiagnosiss® Multiplex Diagnostic System Receives FDA 510(k) Clearance

With this approval, Akonni is poised to enter the $8B molecular diagnostics market. The TruDiagnosis® Multiplex Diagnostic System is a compact point of service molecular diagnostic device which includes the TruDx® 2000 Imager & the TruArray® consumable test kit, both unique & patented technologies developed at Akonni.